In this section you will find Selcia news and up-coming events Selcia is attending.
News & Events
An initiative is under way to develop new drugs for a devastating tropical disease that threatens almost 70 million people in Africa.
Selcia Limited, the international life sciences CRO, has announced a successful inspection of its GMP radiochemistry facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Selcia Limited, the international life sciences CRO, has appointed John Davis to the newly created role of Director of Discovery.
Selcia Limited, the international life sciences CRO, has entered into a drug discovery collaboration with Cantab Anti-Infectives, the goal of which is to accelerate Cantab’s programme to develop improved antibiotics for multidrug resistant Gram-negative bacterial infections based on the polymyxin nucleus.
Selcia has developed new technology to enable drug discovery and development on the target family of peptidyl-prolyl cis-trans isomerases (PPIases).